Correlation Between NYSE Composite and IShares Genomics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and IShares Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and IShares Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and iShares Genomics Immunology, you can compare the effects of market volatilities on NYSE Composite and IShares Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of IShares Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and IShares Genomics.
Diversification Opportunities for NYSE Composite and IShares Genomics
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between NYSE and IShares is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and iShares Genomics Immunology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Genomics Imm and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with IShares Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Genomics Imm has no effect on the direction of NYSE Composite i.e., NYSE Composite and IShares Genomics go up and down completely randomly.
Pair Corralation between NYSE Composite and IShares Genomics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.52 times more return on investment than IShares Genomics. However, NYSE Composite is 1.94 times less risky than IShares Genomics. It trades about -0.04 of its potential returns per unit of risk. iShares Genomics Immunology is currently generating about -0.1 per unit of risk. If you would invest 2,018,860 in NYSE Composite on December 4, 2024 and sell it today you would lose (36,512) from holding NYSE Composite or give up 1.81% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. iShares Genomics Immunology
Performance |
Timeline |
NYSE Composite and IShares Genomics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
iShares Genomics Immunology
Pair trading matchups for IShares Genomics
Pair Trading with NYSE Composite and IShares Genomics
The main advantage of trading using opposite NYSE Composite and IShares Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, IShares Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Genomics will offset losses from the drop in IShares Genomics' long position.NYSE Composite vs. Lincoln Educational Services | NYSE Composite vs. Scholastic | NYSE Composite vs. Integral Ad Science | NYSE Composite vs. Ihuman Inc |
IShares Genomics vs. Global X Genomics | IShares Genomics vs. iShares Cybersecurity and | IShares Genomics vs. iShares Self Driving EV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |